What is the creatinine clearance for a 45‑year‑old male with a serum creatinine of 1.8 mg/dL?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 27, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Creatinine Clearance Calculation for a 45-Year-Old Male with Serum Creatinine 1.8 mg/dL

Direct Answer

Without the patient's weight, creatinine clearance cannot be calculated using the Cockcroft-Gault formula, which is the recommended method for medication dosing decisions. 1

Required Information and Calculation Method

  • The Cockcroft-Gault formula requires four variables: age, weight (kg), serum creatinine (mg/dL), and sex to estimate creatinine clearance. 1, 2

  • Assuming a typical weight of 70 kg (which must be verified with the actual patient), the calculation would be:

    • CrCl = [(140 - 45) × 70 kg] / [72 × 1.8 mg/dL]
    • CrCl = [95 × 70] / 129.6
    • CrCl ≈ 51 mL/min 1, 2

Clinical Interpretation

  • A creatinine clearance of approximately 51 mL/min represents Stage 3A chronic kidney disease (GFR 45-59 mL/min/1.73 m²), indicating moderate kidney impairment that requires dose adjustment for all renally cleared medications. 3

  • Serum creatinine of 1.8 mg/dL alone significantly underestimates the degree of renal impairment—this value appears only mildly elevated but corresponds to loss of approximately half of normal kidney function in a 45-year-old male. 1, 4

  • When serum creatinine rises to 1.8 mg/dL, GFR has already decreased by at least 40%, making creatinine a late indicator of kidney dysfunction. 1

Medication Dosing Implications

  • All medications that are primarily eliminated by the kidneys require dose adjustment when creatinine clearance falls in the 30-60 mL/min range. 1, 3

  • Calculate creatinine clearance before initiating any nephrotoxic medications (aminoglycosides, vancomycin, NSAIDs, contrast agents) and review all current medications for renal appropriateness. 1, 3

  • For drugs with narrow therapeutic indices (vancomycin, aminoglycosides, lithium, digoxin, chemotherapy), consider cystatin C-based equations or direct GFR measurement with exogenous markers to achieve higher precision than Cockcroft-Gault alone. 1

Weight Adjustments for Special Populations

  • For obese patients (BMI ≥ 30 kg/m²), use the mean of actual body weight and ideal body weight in the Cockcroft-Gault equation to improve accuracy. 1, 5

  • Ideal body weight should not be used alone as it systematically underestimates creatinine clearance (mean difference -5.15 mL/min). 5

  • Total body weight alone overestimates creatinine clearance (mean difference +15.91 mL/min), particularly in obese individuals. 5

Critical Clinical Pitfalls

  • Never use serum creatinine alone to assess kidney function—the K/DOQI guidelines explicitly prohibit this practice because it markedly underestimates renal insufficiency. 1, 4, 3

  • The Cockcroft-Gault formula overestimates true GFR by roughly 10-40% because creatinine is both filtered and secreted by renal tubules, with greater overestimation as kidney function declines. 1

  • At a creatinine clearance of ~51 mL/min, tubular secretion of creatinine increases proportionally, causing the formula to overestimate true GFR even more than at higher levels of function. 1

Alternative Assessment Methods

  • For CKD diagnosis and staging (rather than medication dosing), use the 2021 CKD-EPI equation without race, which provides GFR indexed to body surface area (mL/min/1.73 m²). 6, 1

  • When eGFR falls in the 45-59 mL/min/1.73 m² range without albuminuria, measure cystatin C to compute a combined eGFRcr-cys, which improves accuracy and correctly reclassifies approximately 17% of patients. 1

  • Direct GFR measurement using exogenous markers (inulin, iohexol, ¹²⁵I-iothalamate) should be considered for patients with extreme body composition, severe malnutrition, or when dosing narrow-therapeutic-index drugs. 1

References

Guideline

Estimating Creatinine Clearance

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Chronic Kidney Disease Assessment and Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Creatinine Clearance Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.